Hear about how Samantha Conroy is pioneering ex-vivo drug screening in human bladder cancer.
Watch her video here.
In the future, we hope that ex-vivo drug screening of bladder tumours will help to identify effective treatments for individual patients, while also improving quality of life by avoiding ineffective treatments that are lengthy and toxic to the patient, and costly to the NHS. Particularly, if they are not going to help control the spread of a patients’ cancer. Ex-vivo screening will also help to speed up the process of discovering new drugs to treat bladder cancer.
